Clinical Study on Tanggankang Capsule in Treatment of 30 Cases of Diabetic Hepatic Injury
- VernacularTitle:糖肝康胶囊治疗糖尿病性肝损伤30例临床研究
- Author:
Yuexing XIAO
;
Qing NI
;
Qiuhai QIAN
- Publication Type:Journal Article
- Keywords:
diabetes;
hepatic injury;
Tanggankang Capsule
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2006;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the role of Tanggankang Capsule in decreasing blood sugar, regulating blood lipid and protecting liver for the patient of type 2 diabetes with hepatic injury. Methods 60 cases of type 2 diabetes with hepatic injury, and with TCM syndrome of stagnation of liver-qi and deficiency of spleen, dampness-heat and blood stasis were enrolled in the study. Patients were randomly divided into treatment group (Tanggankang Capsule group, n=30) and control group (Metfofmin and Glucurolactone group, n=30), and were administrated for 8 weeks. Results The total effective rate for the improvement of TCM syndromes was 89.9% in the treatment group and 62.4% in the control group, with significant difference between the two groups (P
